Wisconsin Alumni Research Foundation

The Problem

A biologic firm financed and developed a cGMP Fill Finish Lyophilization facility in Madison, Wisconsin. The building was completed in 2008; however, the company was acquired by a larger pharmaceutical firm in 2009. The facility was never occupied and the property was gifted to the Morgridge Research Institute and the Wisconsin Alumni Research Foundation in 2010. WARF wanted to access the capital tied up in the building to support the Foundation’s research mission and sought bio-pharmaceutical facility specific expertise to guide the disposition process.

The Solution

Facility Logix conducted a facility assessment detailing how the existing facility and its bio-pharmaceutical manufacturing fill-finish line could be packaged for prospects. Working with a regional commercial real estate firm Facility Logix pre-qualified prospects, arranged for prospect meetings and tours and provided technical and industry-based information to address prospect questions and further their interest in the opportunity. A follow-on buyer for the facility was located and the sale closed successfully.

Other Projects

LB-1/PX-1

LB-1/PX-1

United Therapeutics Corporation (UT) sought to design and develop the first full service Ex Vivo Lung Perfusion (EVLP) Center in the United States. Time to market was critical for the delivery of the building for initiating US clinical trials.

John Hopkins University Fast Forward

John Hopkins University Fast Forward

Johns Hopkins FastForward business accelerator program sought to understand Baltimore City, regional and statewide lab space market dynamics to guide the design of its planned 1812 Ashland incubator

IBT

IBT

Facility Logix worked with IBT and its real estate representation team to evaluate options for its new facility. We are currently overseeing the design, engineering and build-out of the new facility that will open in September 2016.